Fiserv, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – FI GlobeNewswire July 31, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Fiserv, Inc. (“Fiserv, Inc.” or the “Company”) (NYSE: FI) of a class action securities lawsuit. CLASS DEFINITION: […]

(NASDAQ:CAPR), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor investors who were adversely affected by alleged securities fraud between October 9,

(NASDAQ:REPL), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (“Replimune Group, Inc.” or the “Company”) (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities

Contact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. (CAPR) GlobeNewswire July 31, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The

Investors in Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights – REPL GlobeNewswire July 31, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. (“Replimune Group, Inc.” or the “Company”) (NASDAQ: REPL) of a class action securities

Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year The Clorox Company (NYSE: CLX) today reported results for the fourth quarter and fiscal year 2025, which ended June 30, 2025. Fourth-Quarter Fiscal Year 2025 Summary The following is a summary of key fourth-quarter

— 2Q sales of $1.1 billion, a 6% decrease vs 2Q24 — 2Q EPS of $.38, 2Q adjusted1 EPS of $.30, a $.01 increase vs adjusted1 2Q24 EPS — Strengthened balance sheet primarily through debt reduction of $143 million during the quarter, leading to an improved net debt to 12-month trailing adjusted EBITDA1 ratio of

(NASDAQ:ENVX),(NASDAQ:ENVXW), FREMONT, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Enovix”), a global high-performance battery company, announced that it posted on its website here a letter to shareholders from President and CEO, Dr. Raj Talluri, and CFO, Ryan Benton, discussing the company's second quarter 2025 results. The company will host a

(NASDAQ:YSXT), GUANGZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) — YSX TECH. CO., LTD (the “Company,” “our,” “us” or “YSXT”), a Cayman Islands exempted company that, through its variable interest entities in China, provides comprehensive business solutions mainly for insurance companies and brokerages in China, today announced its financial results for the fiscal year ended March

(NASDAQ:IRTC), Partnership aims to utilize predictive AI to help identify arrhythmias earlier in patient populations with an elevated risk for arrhythmias to enable timely care for millions who remain undiagnosed Commercial offering from this collaboration designed to support scalable population health and value-based care strategies SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies,